Bone Biologics (BBLGW) Payables (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Payables for 2 consecutive years, with $3.6 million as the latest value for Q3 2017.
- Quarterly Payables rose 980.96% to $3.6 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Sep 2017, up 980.96% year-over-year, with the annual reading at $1.5 million for FY2016, N/A changed from the prior year.
- Payables for Q3 2017 was $3.6 million at Bone Biologics, up from $2.5 million in the prior quarter.
- The five-year high for Payables was $3.6 million in Q3 2017, with the low at $335622.0 in Q3 2016.